Skip to main content
Acute myeloid leukemia (AML) is a rare disease that is seen most often in older adults, although it can occur in younger people as well. This webinar discusses the symptoms of AML, how it is diagnosed, risk factors for developing AML, and current treatment options.
CAR T-cell therapy is a type of specialized immunotherapy that uses the patient's own modified T-cells to fight cancer. It is approved to treat certain blood cancers like lymphoma, leukemia, and multiple myeloma.
Nancy Dana underwent a stem cell transplant after being diagnosed with Mantle Cell Lymphoma. In this video, she shares 15 helpful lessons she learned about preparing for a transplant, making the hospital stay as comfortable as possible, and strategies for recovering and approaching life after transplant.
A transplant using the patient's own stem cells (an autologous stem cell transplant) or CAR T-cell therapy are treatment options for patients with certain types of lymphoma.
The COVID 19 pandemic has become an endemic disease that requires ongoing vigilance from stem cell transplant recipients. This presentation reviews current guidelines for when to test for COVID and the varieties of treatments that have become available since the onset of the virus.
Acute myeloid leukemia is a fast-moving cancer that can be fatal in weeks or months without treatment. This presentation reviews the causes, symptoms, and treatments for AML and recent progress in cure rates or prolonged remission for an increasing number of patients.
Genital graft-versus-host-disease can be a lifelong risk for female stem cell or bone marrow transplant recipients. The presentation reviews the symptoms of vaginal and vulvar GVHD and discusses treatments that can restore women to full sexual health and functioning. Many thanks to Kadmon, a Sanofi company, and Syndax Pharmaceuticals, whose support, in part, made this webinar possible.
Myelodysplastic syndrome (MDS) is a blood disorder that can develop into leukemia. There are several treatments for MDS, including stem cell transplantation. This presentation reviews key features of MDS, treatment options and when a transplant is an appropriate remedy.
There are several safe and effective vaccines for COVID-19. These vaccines are recommended for transplant patients in most circumstances. This presentation reviews guidelines, offers recommendations, and answers questions about the benefits of COVID-19 vaccines for transplant patients.
CAR T-cell therapy is a promising new approach for treating certain blood cancers. When undergoing this therapy, patients greatly benefit from having a caregiver who can accompany them throughout the process. This webinar explains CAR T-cell therapy and how caregivers can assist the patent through each stage of the process.